Brief: Cabaletta Bio Files For Mixed Shelf Of Up To $350 Mln – SEC Filing
16/03/2023 12:44
March 16 (Reuters) - Cabaletta Bio Inc CABA.O :
* CABALETTA BIO INC FILES FOR MIXED SHELF OF UP TO $350
MILLION –
SEC FILING
* CABALETTA BIO INC - SALES AGREEMENT PROSPECTUS COVERING
OFFERING
OF UP TO $100 MILLION OF COMMON STOCK THAT MAY BE ISSUED AND
SOLD FROM TIME TO TIME
Further company coverage: CABA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cabaletta Bio
See all newsCabaletta Bio Q1 net loss widens as R&D costs rise
Brief: First Patients Dosed With Cabaletta Bio’S Rese-Cel Manufactured On Cellares' Automated Cell Shuttle™ Platform
Brief: IND Amendment Clearance Obtained For Clinical Manufacturing Of Rese-Cel From Cabaletta Bio Using Cellares' Automated Platforms
Cabaletta Bio reports smaller-than-expected Q3 loss
U.S. RESEARCH ROUNDUP-Beacon Financial, Comerica, Doximity